MedDataX Logo

Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease

NCT ID: NCT00894426

Last Updated: 2010-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the perception of chronic obstructive pulmonary disease (COPD) patients in symptoms related to morning activities. Also the researchers investigated how to describe the impact of symptoms on sleep quality and how to use the medication in Korea COPD treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COPD Symptom Morning activity Questionnaire

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Morning Symptoms (+)

No interventions assigned to this group

2

Morning Symptoms (-)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD outpatients over 45 years old
* Lung function: post-FEV1 \< 50%
* Current or ex-smoker \> 10 packs per year
* Patients who were not on medication of ISC/FC at least 2 weeks

Exclusion Criteria

* Ongoing exacerbation of COPD or within the previous 3 months
* History of asthma or allergic rhinitis
* Lung cancer or any other significant respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease, tuberculosis, sarcoidosis
* Current participation in an interventional clinical trial
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joonwoo Bahn

Role: STUDY_DIRECTOR

Astrazenca Korea, Medical Department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Daegu, , South Korea

Site Status

Research Site

Gyongiju, , South Korea

Site Status

Research Site

Pohang, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RKR-DUM-2009/1

Identifier Type: -

Identifier Source: org_study_id